Perceptive Advisors LLC Lyra Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $2.39 Billion
- Q1 2025
A detailed history of Perceptive Advisors LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 12,757,562 shares of LYRA stock, worth $1.15 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,757,562
Previous 12,757,562
-0.0%
Holding current value
$1.15 Million
Previous $2.68 Million
38.11%
% of portfolio
0.07%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding LYRA
# of Institutions
57Shares Held
25MCall Options Held
56.6KPut Options Held
33.9K-
Black Rock Inc. New York, NY2.83MShares$254,6980.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$158,9020.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.39MShares$125,1110.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$95,2330.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$91,4400.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $2.86M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...